Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
-
'Sarcastic' Hamilton shows frustration as Ferrari struggle again
-
Three in a row Piastri wins in Miami to lead McLaren one-two
-
Scheffler ties 72-hole PGA record in CJ Cup Byron Nelson romp
-
Nicaragua says quitting UNESCO over press prize award
-
Oscar Piastri wins Miami Grand Prix to lead McLaren one-two
-
Bednarek runs this year's world-best 200m to win at Miami Grand Slam
-
'Lucky number seven' for Ruud after beating Draper to clinch Madrid Open
-
China's Zhao leads Williams 11-6 in world snooker final
-
Far-right candidate tops Romania's presidential rerun
-
Ryu takes wire-to-wire win at LPGA Black Desert Championship
-
Marseille held by fellow Champions League hopefuls Lille
-
'Lonely' Palou cruises to win at IndyCar Alabama Grand Prix
-
Zelensky says does 'not believe' Russian truce pledge
-
US Fed expected to pause rate cuts again, await clarity on tariffs
-
Ruud beats Draper to win Madrid Open and claim maiden Masters
-
Far-right candidate leads Romania's presidential rerun
-
Parag's six sixes in a row, Pant flops in IPL
-
Howe hails Newcastle's 'ruthless' Isak after VAR drama in Brighton draw
-
Pant woes continue as Lucknow lose to Punjab in IPL
-
'Thunderbolts' strikes big, topping N.America box office
-
Kompany player-led shake-up returns Bayern to Bundesliga summit
-
Leverkusen draw hands Kane's Bayern Bundesliga title
-
Chelsea sink champions Liverpool, Man Utd crash at Brentford
-
Bielle-Biarrey lifts Bordeaux past Toulouse and into Champions Cup final
-
Chelsea beat champions Liverpool to boost top five push
-
Hammers' Potter reveals Paqueta's tears of frustration at Spurs draw
-
Lyon's Champions League hopes hit by loss to Lens
-
Israel vows retaliation against Iran, Yemen's Huthis over airport attack
-
Man Utd 'need to change' after Brentford loss: Amorim
-
China's Zhao dominates Williams 7-1 in first session of World Snooker final
-
Zelensky says does 'not believe' Russian truce promises
-
Bielle-Biarrey double lifts Bordeaux past champions Toulouse and into Champions Cup final
-
Trump says 'I don't know' if must uphold US Constitution as president
-
Brazil police foil Lady Gaga gig bomb plot
-
Godolphin in full bloom as Desert Flower wins 1000 Guineas
-
Almeida wins Tour de Romandie as Evenepoel claims closing time-trial
-
Bolsonaro leaves hospital three weeks after abdominal surgery
-
Man Utd crash at Brentford, Isak rescues Newcastle
-
Romanians vote in tense presidential rerun as far right eyes win
-
Lyon see off Racing to set up Challenge Cup final against Bath
-
Kolkata survive Parag's six-hitting blitz to clinch IPL thriller
-
Israel vows retaliation against Yemen's Huthis over airport attack
-
Mbappe maintains Real Madrid Liga dream in Celta thriller
-
UNESCO says Nicaragua quitting over press prize award
-
Church donation box goes digital in Greece
-
Germans mark liberation of Ravensbrueck Nazi camp
-
Missile hits Israel airport area in Huthi-claimed attack
-
DeChambeau eyes PGA Championship battle after South Korea LIV win
-
Chinese president to visit Russia on May 7-10: Kremlin
-
'We don't care': weddings go on in Pakistan's Kashmir border
NYSE - LSE
Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to report its first quarter 2025 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
Y.Nakamura--AMWN
